Novartis Navigates Volatile Market Waters as Generic Rivals Challenge Core Revenue Streams
The pharmaceutical landscape is witnessing a significant shift as Novartis grapples with the dual pressures of maintaining innovation while defending its established
by 
Josh Weiner
Josh Weiner
